Built-in adjuvants for use in vaccines

This publication has 89 references indexed in Scilit:

• Three types of humanCpG motifs differentially modulate and augment immunogenicity of nonviral and viral repliconDNA vaccines as built‐in adjuvants
  European Journal of Immunology, 2012
• Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
  Proceedings of the National Academy of Sciences, 2011
• Carbohydrate-Monophosphoryl Lipid A Conjugates Are Fully Synthetic Self-Adjuvanting Cancer Vaccines Eliciting Robust Immune Responses in the Mouse
  ACS Chemical Biology, 2011
• Toward self-adjuvanting subunit vaccines: Model peptide and protein antigens incorporating covalently bound toll-like receptor-7 agonistic imidazoquinolines
  Bioorganic & Medicinal Chemistry Letters, 2011
• Towards a Fully Synthetic MUC1‐Based Anticancer Vaccine: Efficient Conjugation of Glycopeptides with Mono‐, Di‐, and Tetravalent Lipopeptides Using Click Chemistry
  Chemistry – A European Journal, 2011
• Synthesis of MUC1–lipopeptide chimeras
  Chemical Communications, 2010
• Fully Synthetic Vaccines Consisting of Tumor‐Associated MUC1 Glycopeptides and a Lipopeptide Ligand of the Toll‐like Receptor 2
  Angewandte Chemie International Edition, 2010
• NK T cells provide lipid antigen-specific cognate help for B cells
  Proceedings of the National Academy of Sciences, 2008
• Robust immune responses elicited by a fully synthetic three-component vaccine
  Nature Chemical Biology, 2007
• Synthesis of a Highly Pure Lipid Core Peptide Based Self-Adjuvanting Triepitopic Group A Streptococcal Vaccine, and Subsequent Immunological Evaluation
  Journal of Medicinal Chemistry, 2006